Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥65 years of age (The Italian longitudinal study on aging)

被引:33
|
作者
Solfrizzi, V
Panza, F
Colacicco, AM
Capurso, C
D'Introno, A
Torres, F
Baldassarre, G
Capurso, A
机构
[1] Univ Bari Policlin, Ctr Lipoprotein Metab, Dept Geriatr, I-70124 Bari, Italy
[2] Miulli Reg Hosp, Div Geriatr, Bari, Italy
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 89卷 / 07期
关键词
D O I
10.1016/S0002-9149(02)02192-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High levels of serum lipoprotein(a) [Lp(a)] have been associated with increased risk of coronary artery disease (CAD), but this association apparently is not confirmed in elderly people. We evaluated the interactions of Lp(a) with lipid and nonlipid CAD risk factors in a sample of subjects enrolled in the prevalence survey (1992 to 1993) of the Italian Longitudinal Study on Aging (ILSA). The entire population consisted of 5,632 elderly people, aged 65 to 84 years, randomly selected in 8 Italian municipalities. The present cross-sectional study included 400 free-living elderly subjects (74 +/- 6 years) from the randomized cohort of Casamossima (Bari, Southern Italy) (n = 704). The results showed that in the elderly population, high serum Lp(a) is a CAD risk factor dependent on type 2 diabetes mellitus and elevoted low-density lipoprotein (LDL) cholesterol levels. In particular, the combined effect of high Lp(a) (greater than or equal to20 mg/ dl) and high LDL cholesterol (greater than or equal to3.63 mmol/L [greater than or equal to140 mg/dl]), increases coronary risk by 2.75 (95% confidence interval 7.70 to 0.99); finally, the effect of Lp(a) greater than or equal to20 mg/dl and LDL cholesterol greater than or equal to3.63 mmol/L (greater than or equal to140 mg/dl), combined with type 2 diabetes mellitus, increases risk of CAD by 6.65 (95% confidence interval 35.40 to 1.25). In the elderly, elevated Lp(a) levels appear not to be an independent predictor of CAD, but this lipoprotein is a risk factor only in subjects with type 2 diabetes mellitus and elevated LDL cholesterol. (C) 2002 by Excerpta Medica, Inc.
引用
收藏
页码:825 / 829
页数:5
相关论文
共 50 条
  • [41] Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering
    Jones, Peter H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 41L - 47L
  • [42] Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol
    Sniderman, Allan D.
    Islam, Shofiqul
    McQueen, Matthew
    Pencina, Michael
    Furberg, Curt D.
    Thanassoulis, George
    Yusuf, Salim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
  • [43] Association of High-Density Lipoprotein Cholesterol With Coronary Heart Disease Risk Across Categories of Low-Density Lipoprotein Cholesterol: The Atherosclerosis Risk in Communities Study
    Muntner, Paul
    Lee, Fleur
    Astor, Brad C.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (03): : 173 - 180
  • [44] Oxidized Low-Density Lipoprotein Is Negatively Correlated With Lecithin-Cholesterol Acyltransferase Activity in Type 2 Diabetes Mellitus
    Nakhjavani, Manouchehr
    Asgharani, Firouzeh
    Khalilzadeh, Omid
    Esteghamati, Alireza
    Ghaneei, Azam
    Morteza, Afsaneh
    Anvari, Mehdi
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (02): : 92 - 95
  • [45] Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Nobuya Inagaki
    Maki Goda
    Shoko Yokota
    Nobuko Maruyama
    Hiroaki Iijima
    Advances in Therapy, 2015, 32 : 1085 - 1103
  • [46] Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment
    Yamaji, Takayuki
    Harada, Takahiro
    Kajikawa, Masato
    Maruhashi, Tatsuya
    Kishimoto, Shinji
    Yusoff, Farina Mohamad
    Chayama, Kazuaki
    Goto, Chikara
    Nakashima, Ayumu
    Tomiyama, Hirofumi
    Takase, Bonpei
    Kohro, Takahide
    Suzuki, Toru
    Ishizu, Tomoko
    Ueda, Shinichiro
    Yamazaki, Tsutomu
    Furumoto, Tomoo
    Kario, Kazuomi
    Inoue, Teruo
    Watanabe, Kentaro
    Takemoto, Yasuhiko
    Hano, Takuzo
    Sata, Masataka
    Ishibashi, Yutaka
    Node, Koichi
    Maemura, Koji
    Ohya, Yusuke
    Furukawa, Taiji
    Ito, Hiroshi
    Yamashina, Akira
    Koba, Shinji
    Higashi, Yukihito
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (04) : 478 - 500
  • [47] High low-density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions
    Hasegawa, Shoko
    Nakano, Toshiaki
    Mukai, Yasushi
    Matsukuma, Yuta
    Yotsueda, Ryusuke
    Tsuchimoto, Akihiro
    Fujisaki, Kiichiro
    Tsuruya, Kazuhiko
    Tsutsui, Hiroyuki
    Kitazono, Takanari
    THERAPEUTIC APHERESIS AND DIALYSIS, 2021, 25 (03) : 296 - 303
  • [48] Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
    Lotta, Luca A.
    Stewart, Isobel D.
    Sharp, Stephen J.
    Day, Felix R.
    Burgess, Stephen
    Luan, Jian'an
    Bowker, Nicholas
    Cai, Lina
    Li, Chen
    Wittemans, Laura B. L.
    Kerrison, Nicola D.
    Khaw, Kay-Tee
    McCarthy, Mark I.
    O'Rahilly, Stephen
    Scott, Robert A.
    Savage, David B.
    Perry, John R. B.
    Langenberg, Claudia
    Wareham, Nicholas J.
    JAMA CARDIOLOGY, 2018, 3 (10) : 957 - 966
  • [49] Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study
    Tani, Shigemasa
    Yagi, Tsukasa
    Atsumi, Wataru
    Kawauchi, Kenji
    Matsuo, Rei
    Hirayama, Atsushi
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [50] Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Inagaki, Nobuya
    Goda, Maki
    Yokota, Shoko
    Maruyama, Nobuko
    Iijima, Hiroaki
    ADVANCES IN THERAPY, 2015, 32 (11) : 1085 - 1103